Cost utility analysis of long acting beta agonists versus leukotriene receptor antagonists in older adults with asthma receiving concomitant inhaled corticosteroid therapy
asthma control. The aim of this study was to evaluate the cost-utility of ICS+LABA compared with ICS+LTRA in older adults with asthma. A Markov model was developed ... estimate the incremental costs and quality adjusted…

